BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28596262)

  • 1. Optimal Surveillance Strategies After Surgery for Renal Cell Carcinoma.
    Tyson MD; Chang SS
    J Natl Compr Canc Netw; 2017 Jun; 15(6):835-840. PubMed ID: 28596262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.
    Stewart SB; Thompson RH; Psutka SP; Cheville JC; Lohse CM; Boorjian SA; Leibovich BC
    J Clin Oncol; 2014 Dec; 32(36):4059-65. PubMed ID: 25403213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.
    Smaldone MC; Fung C; Uzzo RG; Haas NB
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):765-91. PubMed ID: 21763967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current management of renal cell carcinoma.
    Kuusk T; Grivas N; de Bruijn R; Bex A
    Minerva Med; 2017 Aug; 108(4):357-369. PubMed ID: 28176516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urological cancer: towards rational post-nephrectomy follow-up guidelines in RCC.
    Patard JJ; Escudier B
    Nat Rev Clin Oncol; 2015 Mar; 12(3):131-2. PubMed ID: 25668729
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal cell carcinoma: what the surgeon and treating physician need to know.
    Chapin BF; Delacroix SE; Wood CG
    AJR Am J Roentgenol; 2011 Jun; 196(6):1255-62. PubMed ID: 21606286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data.
    Speed JM; Trinh QD; Choueiri TK; Sun M
    Curr Urol Rep; 2017 Feb; 18(2):15. PubMed ID: 28213859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Renal Cell Carcinoma Surveillance Guidelines: Competing Trade-Offs.
    Lobo JM; Nelson M; Nandanan N; Krupski TL
    J Urol; 2016 Jun; 195(6):1664-70. PubMed ID: 26778713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
    Thorstenson A; Harmenberg U; Lindblad P; Ljungberg B; Lundstam S;
    Scand J Urol; 2016; 50(1):2-8. PubMed ID: 26202573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
    Goebell PJ; Ivanyi P; Bedke J; Bergmann L; Berthold D; Boegemann M; Busch J; Doehn C; Krege S; Retz M; Amsberg GV; Grimm MO; Gruenwald V
    Future Oncol; 2020 Oct; 16(29):2307-2328. PubMed ID: 32964728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAU guidelines on renal cell carcinoma: the 2010 update.
    Ljungberg B; Cowan NC; Hanbury DC; Hora M; Kuczyk MA; Merseburger AS; Patard JJ; Mulders PF; Sinescu IC;
    Eur Urol; 2010 Sep; 58(3):398-406. PubMed ID: 20633979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
    Soares A; Monteiro FSM; Maluf FC; Bastos DA; Jardim DL; Sasse AD; Gonçalves E Silva A; Fay AP; da Rosa DAR; Wierman E; Kater F; Schutz FA; de Oliveira FNG; Morbeck IAP; Rinck JA; da Trindade KM; Maia MC; Souza VC; da Silva Neto DCV; de Almeida E Paula F; Korkes F; Carvalhal GF; Nogueira L; de Carvalho Fernandes R; Dos Reis RB; Matheus WE; Busato WFS; da Costa WH; de Cássio Zequi S
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1829-1845. PubMed ID: 32410064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
    Motzer RJ; Jonasch E; Agarwal N; Alva A; Bagshaw H; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Gunn A; Haas N; Johnson M; Kapur P; King J; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Sweis R; Zibelman M; Schonfeld R; Stein M; Gurski LA
    J Natl Compr Canc Netw; 2024 Feb; 22(1):4-16. PubMed ID: 38394781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
    Motzer RJ; Jonasch E; Agarwal N; Alva A; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Haas N; Hancock SL; Kapur P; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Nandagopal L; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Dwyer MA; Gurski LA; Motter A
    J Natl Compr Canc Netw; 2022 Jan; 20(1):71-90. PubMed ID: 34991070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.
    Al-Ali BM; Ress AL; Gerger A; Pichler M
    Anticancer Res; 2012 Sep; 32(9):3727-32. PubMed ID: 22993312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
    Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
    BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma. Guidelines for diagnosis and treatment.
    Miller K
    Urol Int; 1999; 63(1):6-9. PubMed ID: 10592483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post partial nephrectomy surveillance imaging: an evidence-based approach.
    Marconi L; Gorin MA; Allaf ME
    Curr Urol Rep; 2015 Apr; 16(4):23. PubMed ID: 25749808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant treatment for renal cell carcinoma: do we finally have a major breakthrough?
    Patel DN; Figlin RA; Kim HL
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):907-914. PubMed ID: 27930642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
    Motzer RJ; Jonasch E; Boyle S; Carlo MI; Manley B; Agarwal N; Alva A; Beckermann K; Choueiri TK; Costello BA; Derweesh IH; Desai A; George S; Gore JL; Haas N; Hancock SL; Kyriakopoulos C; Lam ET; Lau C; Lewis B; Madoff DC; McCreery B; Michaelson MD; Mortazavi A; Nandagopal L; Pierorazio PM; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Somer B; Sosman J; Dwyer MA; Motter AD
    J Natl Compr Canc Netw; 2020 Sep; 18(9):1160-1170. PubMed ID: 32886895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.